Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 330 participants.

Also called NCT06603870

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 330 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06603870
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06603870. Allocation not applicable; no masking; primary purpose treatment. Start 2024-12-19 (actual); primary completion 2029-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Acronym
STREAM-Line
Condition
Venous Thromboembolism
Condition
Cancer
Condition
Upper Extremity Deep Vein Thrombosis
Condition
Catheter-Related Infections
Intervention (Drug)
Anticoagulation Therapy
Lead sponsor
Ottawa Hospital Research Institute (class: other)

Record details

Record id
cardio:ct-nct06603870
Content hash
df4cd39e46829fb9e42c06ef7ce286dc29d00759409f9a6d058275d3d54d2abd